107 related articles for article (PubMed ID: 22046854)
1. T4b breast masses: a retrospective review of 12 cases presenting to a metropolitan tertiary care center.
Downing S; Akinrinlola A; Siram SM; DeWitty RL; Paul H; Dawson K; Frederick WA
J Natl Med Assoc; 2011 Aug; 103(8):757-61. PubMed ID: 22046854
[TBL] [Abstract][Full Text] [Related]
2. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women.
McCarthy EP; Burns RB; Coughlin SS; Freund KM; Rice J; Marwill SL; Ash A; Shwartz M; Moskowitz MA
Ann Intern Med; 1998 May; 128(9):729-36. PubMed ID: 9556466
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of triple-negative tumors in an urban cancer center.
Lund MJ; Butler EN; Bumpers HL; Okoli J; Rizzo M; Hatchett N; Green VL; Brawley OW; Oprea-Ilies GM; Gabram SG
Cancer; 2008 Aug; 113(3):608-15. PubMed ID: 18484596
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy use and outcomes among older women with ER-positive and ER-negative stage I breast cancer.
Shen X; Anne PR; Keith SW; Wojcieszynski A; Mishra MV; Bar-Ad V; Showalter TN
Am J Clin Oncol; 2014 Jun; 37(3):241-7. PubMed ID: 23241502
[TBL] [Abstract][Full Text] [Related]
5. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
6. Prognosis of women with pT4b breast cancer: the significance of this category in the TNM system.
Harms K; Wittekind C
Eur J Surg Oncol; 2009 Jan; 35(1):38-42. PubMed ID: 18215492
[TBL] [Abstract][Full Text] [Related]
7. The impact of socioeconomic status and race on trial participation for older women with breast cancer.
Gross CP; Filardo G; Mayne ST; Krumholz HM
Cancer; 2005 Feb; 103(3):483-91. PubMed ID: 15597407
[TBL] [Abstract][Full Text] [Related]
8. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
9. Probabilities of death from breast cancer and other causes among female breast cancer patients.
Schairer C; Mink PJ; Carroll L; Devesa SS
J Natl Cancer Inst; 2004 Sep; 96(17):1311-21. PubMed ID: 15339969
[TBL] [Abstract][Full Text] [Related]
10. Race, socioeconomic status, and breast cancer treatment and survival.
Bradley CJ; Given CW; Roberts C
J Natl Cancer Inst; 2002 Apr; 94(7):490-6. PubMed ID: 11929949
[TBL] [Abstract][Full Text] [Related]
11. Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer.
McBride R; Hershman D; Tsai WY; Jacobson JS; Grann V; Neugut AI
Cancer; 2007 Sep; 110(6):1201-8. PubMed ID: 17701948
[TBL] [Abstract][Full Text] [Related]
12. The influence of race, ethnicity, and individual socioeconomic factors on breast cancer stage at diagnosis.
Lantz PM; Mujahid M; Schwartz K; Janz NK; Fagerlin A; Salem B; Liu L; Deapen D; Katz SJ
Am J Public Health; 2006 Dec; 96(12):2173-8. PubMed ID: 17077391
[TBL] [Abstract][Full Text] [Related]
13. Analysis of Sociodemographic, Clinical, and Genomic Factors Associated With Breast Cancer Mortality in the Linked Surveillance, Epidemiology, and End Results and Medicare Database.
Robinson TJ; Wilson LE; Marcom PK; Troester M; Lynch CF; Hernandez BY; Parrilla E; Brauer HA; Dinan MA
JAMA Netw Open; 2021 Oct; 4(10):e2131020. PubMed ID: 34714340
[TBL] [Abstract][Full Text] [Related]
14. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
15. Early and Locally Advanced Metaplastic Breast Cancer: Presentation and Survival by Receptor Status in Surveillance, Epidemiology, and End Results (SEER) 2010-2014.
Schroeder MC; Rastogi P; Geyer CE; Miller LD; Thomas A
Oncologist; 2018 Apr; 23(4):481-488. PubMed ID: 29330212
[TBL] [Abstract][Full Text] [Related]
16. Racial differences in breast carcinoma survival.
Joslyn SA; West MM
Cancer; 2000 Jan; 88(1):114-23. PubMed ID: 10618613
[TBL] [Abstract][Full Text] [Related]
17. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome.
Ihemelandu CU; Leffall LD; Dewitty RL; Naab TJ; Mezghebe HM; Makambi KH; Adams-Campbell L; Frederick WA
Ann Surg Oncol; 2007 Oct; 14(10):2994-3003. PubMed ID: 17647064
[TBL] [Abstract][Full Text] [Related]
18. The prognosis of tumors with only microscopic skin involvement without clinical T4b signs is significantly better than T4b tumors in breast carcinoma.
Duraker N; Batı B; Caynak ZC; Demir D; Kurtuluş I
Breast J; 2011; 17(1):47-55. PubMed ID: 21129094
[TBL] [Abstract][Full Text] [Related]
19. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999-2004.
Brown M; Tsodikov A; Bauer KR; Parise CA; Caggiano V
Cancer; 2008 Feb; 112(4):737-47. PubMed ID: 18189290
[TBL] [Abstract][Full Text] [Related]
20. Regional and racial disparities in breast cancer-specific mortality.
Grann V; Troxel AB; Zojwalla N; Hershman D; Glied SA; Jacobson JS
Soc Sci Med; 2006 Jan; 62(2):337-47. PubMed ID: 16051406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]